Trial Radar AI | ||
|---|---|---|
Clinical Trial NCT05038852 for Smoking Cessation, Tobacco is active, not recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here. | ||
One trial matched filter criteria
Card View
Back to Search
M.D. Anderson Cancer CenterAcceptability of Mobile Applications (Apps) to Enhance Smoking Cessation in a Clinical Tobacco Treatment Program - A Pilot Study
Clinical Trial NCT05038852 is an interventional study for Smoking Cessation, Tobacco that is active, not recruiting. It started on April 12, 2019 with plans to enroll 8 participants. Led by M.D. Anderson Cancer Center, it is expected to complete by December 31, 2025. The latest data from ClinicalTrials.gov was last updated on July 29, 2025.
Brief Summary
We will conduct a small-scale randomized controlled trial (RCT) with 24 adult smokers enrolled in the TTP. Participants will receive either the Free4Good mobile app for positive psychology skills training or a breathing relaxation mobile app control (Breathe2Relax). All participants will be receiving tobacco cessation treatment in the Tobacco Treatment Program at MD Anderson as standard of care.
Detailed Description
The aims of this pilot protocol are to test the adherence, acceptability, user satisfaction, and preliminary efficacy of a smartphone mobile health app, Free4Good, which incorporates skills training in positive psychology vs. a relaxation app, Breathe2Relax (control condition), in a small randomized controlled trial of smokers (N = 24). Adherence will be measured directly through app usage data. Acceptability and user satisfaction will be measured via specific items included on a User Satisfaction Questionnaire. Efficacy outcomes include evidence of increased engagement in positive psychology-related quitting strategies (measured by the Quitting Strategies Questionnaire) and smoking abstinence.
Exploratory analyses including covariates such as nicotine dependence, mood, and depressive symptoms may be examined as appropriate, as these measures have been shown to predict abstinence outcomes in a variety of studies.1-4 Changes in mood and/or depressive symptoms may also be characterized
Official Title
Acceptability of Mobile Applications (Apps) to Enhance Smoking Cessation in a Clinical Tobacco Treatment Program - A Pilot Study
Conditions
Smoking CessationTobaccoOther Study IDs
- 2018-0984
- NCI-2021-09413 (Other Identifier) (NCI-CTRP Clinical Trials Registry)
NCT ID Number
Start Date (Actual)
2019-04-12
Last Update Posted
2025-07-29
Completion Date (Estimated)
2025-12-31
Enrollment (Estimated)
8
Study Type
Interventional
PHASE
N/A
Status
Active, not recruiting
Primary Purpose
Prevention
Design Allocation
N/A
Interventional Model
Single Group
Masking
None (Open Label)
Arms / Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
OtherGroup 1 smartphone applications app is designed to help you learn relaxation skills | Smartphone Applications app is designed to help you learn relaxation skills. Smartphone Applications app is designed to help you increase your positive feelings, behaviors, and thoughts. |
OtherGroup 2 smartphone applications app is designed to help you increase your positive feelings, behaviors, and thoughts. | Smartphone Applications app is designed to help you learn relaxation skills. Smartphone Applications app is designed to help you increase your positive feelings, behaviors, and thoughts. |
Primary Outcome Measures
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
To assess the adherence of a smartphone mobile health app. | through study completion, an average of 1 year |
Eligibility Criteria
Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
- MD Anderson patient between the ages of 18 to 65
- current smoker (i.e., at least 1 cigarette or e-cig per day)
- smoking for at least one year,
- willing to set a quit date in the next 30 days,
- not engaged in smoking cessation treatment other than the MDACC Tobacco Treatment Program
- English speaking and ability to read and comprehend English, and 7) currently own an iOS mobile phone (iPhone) using iOS 9.0 or later and reports regular use (at least weekly) of at least 1 iOS app.
- endorsing current suicidal ideation or intent,
- meeting criteria for a current Major Depressive Episode measured by the PHQ-9,
- any medical or psychiatric condition, illness, disorder, or concomitant medication that could compromise participant safety or treatment, as determined by the Principal Investigator or Collaborator,
- subject considered by the investigator an unsuitable candidate for receipt of a smoking cessation treatment or unstable to be followed up throughout the entire duration of the study.
- Pregnant women will not be excluded from participating in the study and any decisions about potential pharmacotherapy will be done as standard of care in the Tobacco Treatment Program, including a consultation with the medical team and a joint decision-making process with the patient to determine the best course of treatment given all co-morbid medical conditions.
M.D. Anderson Cancer Center1128 active trials to exploreNo contact data.
1 Study Locations in 1 Countries
Texas
M D Anderson Cancer Center, Houston, Texas, 77030, United States